Brief: Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results
Nov 21 (Reuters) - Aridis Pharmaceuticals Inc ARDS.O :
* ARIDIS PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS UPDATE
* ARIDIS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.47
Source text for Eikon: ID:nGNX3Xs240
Further company coverage: ARDS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aridis Pharmaceuticals
See all newsBrief: Aridis Pharmaceuticals Inc - On September 7 Nasdaq Announced That It Would Delist Common Stock Of Co
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music